Objectif
Congenital and acquired diseases of the heart are the leading causes of morbidity and mortality in the world today; 7.2 million people die each year due to coronary heart disease, being the first cause of mortality in population above 60 years old, and the second cause after HIV in world wide young population. There is an urgent demand for new methods to repair and replace damaged cardiovascular tissues. One of the most promising ways to achieve this goal is the development of regenerative therapies aided with novel intelligent nanobiomaterials such as bioactive scaffolds. The overall objective of this project is the development of innovative bioactive polymeric scaffolds able to guide tissue formation from dissociated stem cells, for engineering autologous cardiovascular replacements, namely vascular tissues, heart valves and cardiac muscle. Two different strategies will be followed to approach creating new engineered tissue: 1.In vitro tissue engineering: according to the most frequent tissue engineering paradigm, cells will be seeded on a scaffold composed of synthetic polymer or natural material and the tissue will be matured in vitro in a bioreactor, in order to obtain a construct that can be implanted in the appropriate anatomic location as a prosthesis; 2.In vivo tissue engineering: unseeded scaffolds that attract endogenous cells and control cell proliferation and differentiation will be implanted to repopulate and remodel an altered cardiovascular tissue. The strong innovative content of the project is in the realisation of multifunctional scaffolds which can guide complex cellular processes such as adhesion, proliferation and differentiation, processes fundamental for tissue regeneration. It is therefore necessary to design integrated material scaffolds and culture environments, which can appropriately confer biochemical, morphological, electrical and mechanical stimuli to a developing tissue.
Champ scientifique
- social sciencessociologydemographymortality
- medical and health sciencesmedical biotechnologytissue engineering
- medical and health scienceshealth sciencesinfectious diseasesRNA virusesHIV
- medical and health sciencesmedical biotechnologycells technologiesstem cells
- medical and health sciencesmedical biotechnologyimplants
Mots‑clés
Programme(s)
Thème(s)
Appel à propositions
FP7-NMP-2007-LARGE-1
Voir d’autres projets de cet appel
Régime de financement
CP-IP - Large-scale integrating projectCoordinateur
56126 Pisa
Italie
Voir sur la carte
Participants (17)
Participation terminée
20159 MILANO
Voir sur la carte
14220 Praha 4
Voir sur la carte
Participation terminée
SW7 2AZ LONDON
Voir sur la carte
700487 Iasi
Voir sur la carte
Participation terminée
LE13 OPB MELTON MOWBRAY, LEICESTERSHIRE
Voir sur la carte
M13 9PL Manchester
Voir sur la carte
10129 Torino
Voir sur la carte
30625 Hannover
Voir sur la carte
1011 JV AMSTERDAM
Voir sur la carte
43121 PARMA
Voir sur la carte
75014 PARIS
Voir sur la carte
20159 MILANO
Voir sur la carte
3520 FARUM
Voir sur la carte
TS23 4AZ Billingham
Voir sur la carte
D-72770 Reutlingen
Voir sur la carte
91054 Erlangen
Voir sur la carte
28034 Madrid
Voir sur la carte